prohibition partners
prohibition partners · page 4
- Industry Trends
Why the UK’s Steady Medical Cannabis Market Growth Is Its Biggest Advantage
Though less explosive than markets like Germany or Australia, the UK has continued to evolve in a more controlled manner, enabling it to largely avoid the scrutiny and intervention that have accompanied rapid expansion elsewhere.
- Events
Cannabis Europa 2025 – Key Insights Day 2
Below, we’ve summarised the key insights from the vibrant and diverse discussions throughout Day 2 of Cannabis Europa 2025. If you’re keen to dive into the details, we’ll be exploring each session in more detail over the coming weeks.
- Uncategorized
Cannabis Europa 2025 – Key Insights Day 1: Part 1
Today, Cannabis Europa 2025 welcomed hundreds of the world’s leading cannabis voices for its first jam packed day of sessions.
- Data & Analysis
What Comes Next for UK Medical Cannabis?
Though large-scale reform does not currently appear forthcoming, there are small-scale, more targeted measures that could feasibly be taken by UK authorities in the coming years which would be positive for the medical cannabis industry.
- Events
Open Letter Calls on Khan to Address Cannabis Decriminalisation Recommendation at Cannabis Europa 2025
Ahead of this year’s Cannabis Europa conference, taking place between 24–25 June 2025 at the Barbican Centre, London, Prohibition Partners have sent an open invitation to the Mayor of London, Sadiq Khan, to speak publicly on the landmark recommendations of the London Drugs Commission (LDC) during the event.
- Uncategorized
European Cannabis Businesses Get Off to Flying Start in 2025
Welcome to Business of Cannabis’ new weekly strategic digest tracking the financial health, market moves, and corporate developments shaping the European cannabis sector.
- Uncategorized
Europe Prepares for Surge in Medical Cannabis Access as Five Countries Finalise Reforms
A number of countries in Europe are currently at some stage of medical cannabis reform. These reforms are set to lay the foundation for five permanent medical cannabis markets in the region.
- Uncategorized
Public Health, Pilot Projects and Politics: Mapping Adult-Use Cannabis in Europe
We have delved into some of the key data and insights set to be integrated into the new site, providing a taste of what readers can expect. For further exclusive analysis into the European cannabis market, pre-orders for data packages are available now.
- Data & Analysis
From Page to Platform: Prohibition Partners Unveils Interactive Cannabis Intelligence Hub
Prohibition Partners will soon be launching the 10th addition of their industry leading European Cannabis Report, marking the milestone with a ground-up overhaul of its tried and trusted format.
- Events
Global Cannabis Regulatory Summit Unveils Highly-Anticipated Speaker Lineup and Programming Schedule
Renowned experts, regulators, and advocates headline groundbreaking international symposium paving the way forward for the global cannabis industry
- Data & Analysis
UK Has Imported More Cannabis From Spain than Any Other Country Since 2021, New Figures Show
New data acquired from the Home Office by Prohibition Partners and Business of Cannabis shows that since 2021, the UK has imported the bulk of its medical cannabis from Spain.
- Medical
Beyond Chronic Pain: Why Private Clinics are Vital to Making Medical Cannabis Mainstream
The medical cannabis industry is in a precarious situation. The fledgling market is experiencing rapid growth across Europe, indicative of surging demand.
